Stanley Stuart (Bob) Davis is emeritus professor of pharmacy at the University of Nottingham.
Saghir Akhtar is professor in the College of Medicine, Qatar University, and editor in chief of the Journal of Drug Targeting.
David Francis Gerrard is a sports administrator, sports medicine specialist, and former Olympic Games swimming representative from New Zealand.
Nicholas (Nikolaos) A. Peppas is a chemical and biomedical engineer whose leadership in biomaterials science and engineering, drug delivery, bionanotechnology, pharmaceutical sciences, chemical and polymer engineering has provided seminal foundations based on the physics and mathematical theories of nanoscale, macromolecular processes and drug/protein transport and has led to numerous biomedical products or devices.
Drug Development and Industrial Pharmacy is an academic journal that publishes research on aspects of drug development and production, as well as the evaluation of drugs and pharmaceutical products.
Lipid nanoparticles (LNPs) are nanoparticles composed of lipids. They are a novel pharmaceutical drug delivery system, and a novel pharmaceutical formulation. LNPs as a drug delivery vehicle were first approved in 2018 for the siRNA drug Onpattro. LNPs became more widely known in late 2020, as some COVID-19 vaccines that use RNA vaccine technology coat the fragile mRNA strands with PEGylated lipid nanoparticles as their delivery vehicle.
Nial J. Wheate is an Australian pharmaceutical chemist and author at the University of Sydney.
Vladimir Petrovich Torchilin is a Soviet, Russian and American biochemist, pharmacologist, and an expert in medical nanotechnology. Torchillin is a University Distinguished Professor of Pharmaceutical Sciences at Northeastern University. He also serves as a director at both the Center for Translational Cancer Nanomedicine and at the Center for Pharmaceutical Biotechnology and Nanomedicine at Northeastern University.
Aliasger K. Salem is the Associate Vice President for Research at the University of Iowa and Bighley Chair and Professor of Pharmaceutical Sciences at the University of Iowa College of Pharmacy. Salem's academic appointment at the University of Iowa is based in the College of Pharmacy, with additional secondary appointments in the College of Dentistry, Department of Chemical and Biochemical Engineering, Department of Biomedical Engineering, Department of Chemistry, and the Holden Comprehensive Cancer Center. Prior to joining the University of Iowa in 2004, he was a postdoctoral fellow at the Johns Hopkins School of Medicine and completed his PhD at the School of Pharmacy and Pharmaceutical Sciences at the University of Nottingham in the UK.
Tamara Minko is a distinguished professor and chair of the department of pharmaceutics at Rutgers University, Ernest Mario School of Pharmacy. She has an H-index of 43 since 2016 and over 17,800 citations of her work.
Andreas Bernkop-Schnürch is an Austrian pharmaceutical technologist, scientist, pharmacist, entrepreneur, inventor and professor at the Institute of Pharmacy, University of Innsbruck. His research centers on the areas of pharmaceutical sciences, drug delivery, controlled release, bionanotechnology and polymer engineering. He is the inventor of various technologies such as thiolated polymers for that he coined the name thiomers in 2000 and phosphatase triggered charge converting nanoparticles for mucosal drug delivery. From 2016 to 2018 he served as a member of the Scientific Committee of the Innovative Medicines Initiative (IMI) of the European Union in Brussels giving advice on scientific priorities to be included in the Strategic Research Agenda for Horizon 2020. Since 2014 he is on the scientific advisory board of the Nicotine Science Center, Denmark. Andreas Bernkop-Schnürch is the founder of Mucobiomer Biotechnologische Forschungs- und Entwicklungs GmbH, Thiomatrix Forschungs- und Beratungs GmbH and Green River Polymers Forschungs und Entwicklungs GmbH. He is listed as a Highly Cited Researcher of the Institute of Scientific Information. As of December 2022 his publications have been cited 30,000 times and his H-index is 86
María José Alonso Fernandez is a full professor of biopharmaceutics and pharmaceutical technology at the University of Santiago de Compostela. The laboratory she leads is specialized in pharmaceutical nanotechnology and nanomedicine, and her research is oriented to the development of nanostructures for targeted delivery of drugs and vaccines. Her discoveries have led to significant clinical advances in the development of potential new treatments for cancer, ocular diseases, skin diseases, diabetes, obesity and other autoimmune pathologies, as well as new vaccines.
Ijeoma Uchegbu is a Nigerian-British Professor of Pharmacy at University College London where she held the position of Pro-Vice Provost for Africa and the Middle East. She is the Chief Scientific Officer of Nanomerics, a pharmaceutical nanotechnology company specialising in drug delivery solutions for poorly water-soluble drugs, nucleic acids and peptides. She is also a Governor of the Wellcome, a large biomedical research charity. Apart from her highly cited scientific research in Pharmaceutical Nanoscience, Uchegbu is also known for her work in science public engagement and equality and diversity in Science, Technology, Engineering and Mathematics (STEM).
Dr. Jean-Christophe Leroux is a French-Canadian full professor of Drug Formulation and Delivery at the Institute of Pharmaceutical Sciences at the Swiss Federal Institute of Technology ETH Zürich. His research is mainly focused on broadening the field of drug delivery, and the development of biodetoxification systems for the treatment of metabolite disorders. Additionally, he has made important contributions to the field of biomaterials for use in drug delivery.
Abdul Waseh Basit is a professor of pharmaceutics at University College London, and founder of two pharmaceutical biotechnology companies spinning out of UCL. Basit is interested in particular in oral drug delivery and pharmaceutical three-dimensional (3D) printing.
Hamid Ghandehari is an Iranian-American drug delivery research scientist, and a professor in the Departments of Pharmaceutics and Pharmaceutical Chemistry and Biomedical Engineering at the University of Utah. His research is focused in recombinant polymers for drug and gene delivery, nanotoxicology of dendritic and inorganic constructs, water-soluble polymers for targeted delivery and poly(amidoamine) dendrimers for oral delivery.
M.S. Muthu is a pharmaceutical engineer, scientist, inventor and one of the nineteen institute professors at the Department of Pharmaceutical Engineering and Technology, Indian Institute of Technology (BHU), Varanasi, India. He is a researcher in the fields of nanomedicine, targeted drug delivery, and in theranostics nanomedicine for therapy and imaging. Dr. Muthu has completed his Ph.D. research work under the supervision of Prof. Sanjay Singh from the Department of Pharmaceutical Engineering & Technology, IIT (BHU), Varanasi, India. He has done his post-doctoral research in cancer nanotechnology under the supervision of Prof. Feng Si-Shen from the National University of Singapore in 2010 & 2014 (2yrs). Dr. Muthu is an associate professor of Pharmaceutics in the Department of Pharmaceutical Engineering & Technology, IIT(BHU).
Mark Robert Prausnitz is an American chemical engineer, currently Regents’ Professor and J. Erskine Love, Jr. Chair in Chemical & Biomolecular Engineering at the Georgia Institute of Technology, He also serves as adjunct professor of biomedical engineering at Emory University and Adjunct Professor of Chemical & Biomolecular Engineering at the Korea Advanced Institute of Science and Technology. He is known for pioneering microneedle technology for minimally invasive drug and vaccine administration, which has found applications in transdermal, ocular, oral, and sustained release delivery systems.
Vitaliy Khutoryanskiy FRSC is a British and Kazakhstani scientist, Professor of Formulation Science and Royal Society Industry Fellow at the University of Reading. His research focuses on polymers, biomaterials, nanomaterials, drug delivery and pharmaceutical sciences. Khutoryanskiy has published over 200 original research articles, book chapters and reviews; his publications have attracted > 10000 citations and his current h-index is 48:. He received several prestigious awards in recognition for his research in polymers, colloids and drug delivery and also for contributions to research peer-review and mentoring of early career researchers. He holds several honorary professorship titles from different universities.
